Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EnteroMedics Inc    ETRM

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 1,20 M
EBIT 2016 -
Net income 2016 -
Debt 2016 -
Yield 2016 -
Sales 2017 2,00 M
EBIT 2017 -
Net income 2017 -
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 27,3x
Capi. / Sales2017 16,4x
Capitalization 32,7 M
More Financials
Company
EnteroMedics, Inc. is a clinical development stage medical device company that engages in the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.Its proprietary neuroblocking technology is designed to... 
More about the company
Latest news on ENTEROMEDICS INC
01/12 ENTEROMEDICS : Announces vBloc® Neurometabolic Therapy Now Available at MedStar ..
01/11 BIOTECH MOVERS : Illumina, Inc. (NASDAQ:ILMN) and EnteroMedics Inc (NASDAQ:ETRM)
01/10 ENTEROMEDICS INC : EnteroMedics and GenVec Post Substantial Gains as the NASDAQ ..
01/09 BIOTECH MOVERS : EnteroMedics Inc (NASDAQ:ETRM) and Stemline Therapeutics Inc (N..
01/05 ENTEROMEDICS INC. (NASDAQ : ETRM) Files An 8-K Other Events
01/05 ENTEROMEDICS INC : Other Events, Financial Statements and Exhibits (form 8-K)
2016 ENTEROMEDICS : REVERSE SPLIT: 1 of 70
2016 ENTEROMEDICS INC : REVERSE SPLIT: 1 of 15; Reverse Split: 1 of 7
2016 ENTEROMEDICS : Announces Publication in SOARD of ASMBS Position Statement on Vag..
2015 ENTEROMEDICS : Reports Third Quarter 2015 Financial Results and Commercial Progr..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
2016 EXCLUSIVE : U.S. regulator poised to approve Abbott purchase of St Jude - source..
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
2016 Medtech Approvals Of The Strange Kind
2015 EnteroMedics Will Do 1 For 15 Reverse Split - This Is Not A Good Way To Start..
2015 ENTEROMEDICS TO REVERSE SPLIT SHARES : 15
2015 EnteroMedics' (ETRM) CEO Dan Gladney on Q3 2015 Results - Earnings Call Trans..
2015 EnteroMedics - Investors Need To Have Realistic Expectations
Advertisement
Chart ENTEROMEDICS INC
Duration : Period :
EnteroMedics Inc Technical Analysis Chart | ETRM | US29365M2089 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus BUY
Number of Analysts 1
Average target price 140 $
Spread / Average Target 922%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Dan W. Gladney Chairman, President & Chief Executive Officer
Peter M. Delange Senior VP-Operations & Business Development
Scott P. Youngstrom Chief Financial & Compliance Officer
Carl Samuel Goldfischer Independent Class I Director
Nicholas L. Teti Independent Class III Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ENTEROMEDICS INC53.73%33
THERMO FISHER SCIENTIF..3.68%57 788
DANAHER CORPORATION4.52%56 277
BOSTON SCIENTIFIC CORP..10.12%32 435
PHILIPS-0.41%28 566
INTUITIVE SURGICAL, IN..4.82%25 756
More Results